Dysplastic nevus screening: Difference between revisions
| Line 6: | Line 6: | ||
==Overview== | ==Overview== | ||
Patients with dysplastic nevus should undergo regular screening to prevent progression to [[melanoma]] | Patients with dysplastic nevus should undergo regular screening to prevent progression to [[melanoma]]. | ||
==Screening== | ==Screening== | ||
Revision as of 14:31, 25 August 2015
|
Dysplastic nevus Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Dysplastic nevus screening On the Web |
|
American Roentgen Ray Society Images of Dysplastic nevus screening |
|
Risk calculators and risk factors for Dysplastic nevus screening |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Patients with dysplastic nevus should undergo regular screening to prevent progression to melanoma.
Screening
According to the National Cancer Institute, physicians believe that dysplastic nevi are more likely than ordinary moles to develop into a type of skin cancer called melanoma. Because of this, moles should be checked regularly by a physician or nurse specialist, especially if they look unusual; grow larger; or change in color, or outline; or if any changes occur.